News articles about Aetna (NYSE:AET) have trended somewhat positive on Thursday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aetna earned a news impact score of 0.07 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.0665327341453 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the news stories that may have impacted Accern Sentiment’s scoring:
AET has been the subject of several research reports. Morgan Stanley lowered Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target for the company. in a report on Wednesday, December 20th. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Piper Jaffray upgraded Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target for the company in a report on Wednesday, January 3rd. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and lifted their price target for the company from $195.00 to $212.00 in a report on Monday, January 22nd. Finally, Cowen reiterated a “buy” rating and set a $212.00 price target on shares of Aetna in a report on Tuesday, January 30th. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $189.50.
AET traded down $1.10 on Thursday, hitting $176.43. The company had a trading volume of 1,243,509 shares, compared to its average volume of 2,497,278. Aetna has a 1-year low of $128.79 and a 1-year high of $194.40. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.65 and a current ratio of 0.65. The firm has a market cap of $57,963.63, a P/E ratio of 17.89, a price-to-earnings-growth ratio of 1.43 and a beta of 0.67.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The firm had revenue of $14.74 billion during the quarter, compared to analyst estimates of $14.79 billion. During the same period in the previous year, the company earned $0.08 EPS. The company’s revenue for the quarter was down 6.2% on a year-over-year basis. analysts anticipate that Aetna will post 11.02 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, April 12th will be issued a $0.50 dividend. The ex-dividend date is Wednesday, April 11th. This represents a $2.00 annualized dividend and a yield of 1.13%. Aetna’s dividend payout ratio (DPR) is currently 20.28%.
TRADEMARK VIOLATION WARNING: “Aetna (AET) Earns Media Sentiment Rating of 0.07” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/04/19/aetna-aet-earns-media-sentiment-rating-of-0-07.html.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.